Aurobindo Pharma Ltd Financials Statements

Annual and Quarterly P/L, Balance Sheet, Cash Flow & Financial Ratios

Consolidate
Standalone
Financial Year
Dec '23
Sep '23
Jun '23
Mar '23
Dec '22
Total Qtr Revenue cr
7,514.30
7,406.40
6,966.85
6,607.87
6,499.78
Other Income Qtr Cr162.52186.98116.33134.9192.65
Operating Revenues Qtr7,351.787,219.426,850.526,472.966,407.13

*All values are in Cr.

Operating Expenses Qtr
5,750.47
5,845.98
5,699.15
5,470.78
5,452.72
Operating Profit Qtr
1,601.31
1,373.44
1,151.37
1,002.18
954.41
EBIDT Qtr Cr
1,763.83
1,560.42
1,197.95
1,137.09
1,047.06
Depreciation Qtr
423.27
417.50
326.56
345.57
321.40
Net Profit Qtr
936.29
757.18
570.75
506.27
491.26
Basic EPS Qtr
16.04
12.83
9.74
8.64
8.38
Open Demat Account
or Resume your Application
+91 -

personImage